Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract

Purpose: We validate the independent predictive value of Ki-67 in patients with high grade upper tract urothelial carcinoma. Materials and Methods: A total of 475 patients from the international Upper Tract Urothelial Carcinoma Collaboration who underwent extirpative surgery for high grade upper tra...

Full description

Saved in:
Bibliographic Details
Main Authors: Krabbe, Laura-Maria (Author) , Bolenz, Christian (Author)
Format: Article (Journal)
Language:English
Published: May 2015
In: The journal of urology
Year: 2015, Volume: 193, Issue: 5, Pages: 1486-1493
ISSN:1527-3792
DOI:10.1016/j.juro.2014.11.007
Online Access:Verlag, Volltext: http://dx.doi.org/10.1016/j.juro.2014.11.007
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0022534714048368
Get full text
Author Notes:Laura-Maria Krabbe, Aditya Bagrodia, Ahmed Q. Haddad, Payal Kapur, Dina Khalil, Linda S. Hynan, Christopher G. Wood, Jose A. Karam, Alon Z. Weizer, Jay D. Raman, Mesut Remzi, Nathalie Rioux-Leclercq, Andrea Haitel, Marco Roscigno, Christian Bolenz, Karim Bensalah, Arthur I. Sagalowsky, Shahrokh F. Shariat, Yair Lotan and Vitaly Margulis

MARC

LEADER 00000caa a2200000 c 4500
001 1585086789
003 DE-627
005 20240316100547.0
007 cr uuu---uuuuu
008 181211s2015 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.juro.2014.11.007  |2 doi 
035 |a (DE-627)1585086789 
035 |a (DE-576)515086789 
035 |a (DE-599)BSZ515086789 
035 |a (OCoLC)1341026955 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Krabbe, Laura-Maria  |e VerfasserIn  |0 (DE-588)109933764X  |0 (DE-627)85820388X  |0 (DE-576)469280476  |4 aut 
245 1 0 |a Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract  |c Laura-Maria Krabbe, Aditya Bagrodia, Ahmed Q. Haddad, Payal Kapur, Dina Khalil, Linda S. Hynan, Christopher G. Wood, Jose A. Karam, Alon Z. Weizer, Jay D. Raman, Mesut Remzi, Nathalie Rioux-Leclercq, Andrea Haitel, Marco Roscigno, Christian Bolenz, Karim Bensalah, Arthur I. Sagalowsky, Shahrokh F. Shariat, Yair Lotan and Vitaly Margulis 
264 1 |c May 2015 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Available online 11 November 2014 
500 |a Gesehen am 11.12.2018 
520 |a Purpose: We validate the independent predictive value of Ki-67 in patients with high grade upper tract urothelial carcinoma. Materials and Methods: A total of 475 patients from the international Upper Tract Urothelial Carcinoma Collaboration who underwent extirpative surgery for high grade upper tract urothelial carcinoma were included in this study. Immunohistochemical staining for Ki-67 was performed on tissue microarray formed from this patient cohort. Ki-67 expression was assessed in a semiquantitative fashion and considered over expressed at a cutoff of 20%. Multivariate analyses were performed to assess independent predictors of oncologic outcomes and Harrell’s C indices were calculated for predictive models. Results: The median age of the cohort was 69.7 years and 55.2% of patients were male. Ki-67 was over expressed in 25.9% of patients. Ki-67 over expression was significantly associated with ureteral tumor location, higher pT-stage, lymphovascular invasion, sessile tumor architecture, tumor necrosis, concomitant carcinoma in situ and regional lymph node metastases. On Kaplan-Meier analyses over expressed Ki-67 was associated with worse recurrence-free survival (HR 12.6, p <0.001) and cancer specific survival (HR 15.8, p <0.001). On multivariate analysis Ki-67 was an independent predictor of recurrence-free survival (HR 1.6, 95% CI 1.07-2.30, p=0.021) and cancer specific survival (HR 1.9, 95% CI 1.29-2.90, p=0.001). Ki-67 improved Harrell’s C index from 0.66 to 0.70 (p <0.0001) for recurrence-free survival as well as cancer specific survival in our preoperative model, and from 0.81 to 0.82 (p=0.0018) for recurrence-free survival and 0.81 to 0.83 (p=0.005) for cancer specific survival in our postoperative model. Conclusions: Ki-67 was validated as an independent predictor of recurrence-free survival and cancer specific survival in patients treated with extirpative surgery for high grade upper tract urothelial carcinoma in a large, multi-institutional cohort. 
650 4 |a biological markers 
650 4 |a carcinoma 
650 4 |a Ki-67 antigen 
650 4 |a transitional cell 
650 4 |a urinary tract 
700 1 |a Bolenz, Christian  |d 1976-  |e VerfasserIn  |0 (DE-588)133152707  |0 (DE-627)537509852  |0 (DE-576)29965754X  |4 aut 
773 0 8 |i Enthalten in  |t The journal of urology  |d New York, NY [u.a.] : Elsevier, 1917  |g 193(2015), 5, Seite 1486-1493  |h Online-Ressource  |w (DE-627)313118213  |w (DE-600)2007912-6  |w (DE-576)095660194  |x 1527-3792  |7 nnas  |a Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract 
773 1 8 |g volume:193  |g year:2015  |g number:5  |g pages:1486-1493  |g extent:8  |a Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract 
856 4 0 |u http://dx.doi.org/10.1016/j.juro.2014.11.007  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0022534714048368  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20181211 
993 |a Article 
994 |a 2015 
998 |g 133152707  |a Bolenz, Christian  |m 133152707:Bolenz, Christian  |d 60000  |d 63100  |e 60000PB133152707  |e 63100PB133152707  |k 0/60000/  |k 1/60000/63100/  |p 15 
999 |a KXP-PPN1585086789  |e 3037393483 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"8 S."}],"relHost":[{"id":{"issn":["1527-3792"],"zdb":["2007912-6"],"eki":["313118213"]},"origin":[{"dateIssuedDisp":"1917-","dateIssuedKey":"1917","publisher":"Elsevier ; Lippincott Williams & Wilkins","publisherPlace":"New York, NY [u.a.] ; Hagerstown, Md."}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"official journal of the American Urological Society","title":"The journal of urology","title_sort":"journal of urology"}],"recId":"313118213","language":["eng"],"corporate":[{"display":"American Urological Association","roleDisplay":"Herausgebendes Organ","role":"isb"}],"note":["Gesehen am 25.03.2022"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tractThe journal of urology","part":{"extent":"8","volume":"193","text":"193(2015), 5, Seite 1486-1493","pages":"1486-1493","issue":"5","year":"2015"},"pubHistory":["1.1917 -"]}],"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"May 2015"}],"id":{"doi":["10.1016/j.juro.2014.11.007"],"eki":["1585086789"]},"name":{"displayForm":["Laura-Maria Krabbe, Aditya Bagrodia, Ahmed Q. Haddad, Payal Kapur, Dina Khalil, Linda S. Hynan, Christopher G. Wood, Jose A. Karam, Alon Z. Weizer, Jay D. Raman, Mesut Remzi, Nathalie Rioux-Leclercq, Andrea Haitel, Marco Roscigno, Christian Bolenz, Karim Bensalah, Arthur I. Sagalowsky, Shahrokh F. Shariat, Yair Lotan and Vitaly Margulis"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Available online 11 November 2014","Gesehen am 11.12.2018"],"language":["eng"],"recId":"1585086789","title":[{"title_sort":"Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract","title":"Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract"}],"person":[{"given":"Laura-Maria","family":"Krabbe","role":"aut","roleDisplay":"VerfasserIn","display":"Krabbe, Laura-Maria"},{"family":"Bolenz","given":"Christian","roleDisplay":"VerfasserIn","display":"Bolenz, Christian","role":"aut"}]} 
SRT |a KRABBELAURMULTIINSTI2015